Literature DB >> 22554845

Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts.

Mario Thevis1, Wilhelm Schänzer, Hans Geyer, Detlef Thieme, Joachim Grosse, Claudia Rautenberg, Ulrich Flenker, Simon Beuck, Andreas Thomas, Ruben Holland, Jiri Dvorak.   

Abstract

The administration of musk extract, that is, ingredients obtained by extraction of the liquid secreted from the preputial gland or resulting grains of the male musk deer (eg, Moschus moschiferus), has been recommended in Traditional Chinese Medicine (TCM) applications and was listed in the Japanese pharmacopoeia for various indications requiring cardiovascular stimulation, anti-inflammatory medication or androgenic hormone therapy. Numerous steroidal components including cholesterol, 5α-androstane-3,17-dione, 5β-androstane-3,17-dione, androsterone, etiocholanolone, epiandrosterone, 3β-hydroxy-androst-5-en-17-one, androst-4-ene-3,17-dione and the corresponding urea adduct 3α-ureido-androst-4-en-17-one were characterised as natural ingredients of musk over several decades, implicating an issue concerning doping controls if used for the treatment of elite athletes. In the present study, the impact of musk extract administration on sports drug testing results of five females competing in an international sporting event is reported. In the course of routine doping controls, adverse analytical findings concerning the athletes' steroid profile, corroborated by isotope-ratio mass spectrometry (IRMS) data, were obtained. The athletes' medical advisors admitted the prescription of TCM-based musk pod preparations and provided musk pod samples for comparison purposes to clarify the antidoping rule violation. Steroid profiles, IRMS results, literature data and a musk sample obtained from a living musk deer of a local zoo conclusively demonstrated the use of musk pod extracts in all cases which, however, represented a doping offence as prohibited anabolic-androgenic steroids were administered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554845     DOI: 10.1136/bjsports-2012-090988

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  7 in total

Review 1.  Steroids in traditional Chinese medicine: what is the evidence?

Authors:  Foon Yin Fung; Yeh Ching Linn
Journal:  Singapore Med J       Date:  2017-03       Impact factor: 1.858

2.  Neuroprotective effect of a formula, moschus combined with borneolum synthcticum, from traditional chinese medicine on ischemia stroke in rats.

Authors:  Xin-Hua Xia; Qiang Li; Mei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-25       Impact factor: 2.629

Review 3.  Anabolic agents: recent strategies for their detection and protection from inadvertent doping.

Authors:  Hans Geyer; Wilhelm Schänzer; Mario Thevis
Journal:  Br J Sports Med       Date:  2014-03-14       Impact factor: 13.800

4.  A Network Pharmacology Approach to Investigate the Active Compounds and Mechanisms of Musk for Ischemic Stroke.

Authors:  Changlin Zhang; Yingdi Liao; Lingling Liu; Yifan Sun; Shaoqin Lin; Jiaying Lan; Hui Mao; Haoxuan Chen; Yuanqi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-03       Impact factor: 2.629

Review 5.  Dietary Supplement and Food Contaminations and Their Implications for Doping Controls.

Authors:  Katja Walpurgis; Andreas Thomas; Hans Geyer; Ute Mareck; Mario Thevis
Journal:  Foods       Date:  2020-07-27

6.  From non-targeted to targeted GC-MS metabolomics strategy for identification of TCM preparations containing natural and artificial musk.

Authors:  Meng Ding; Jun-Li Fan; Dong-Fang Huang; Yue Jiang; Meng-Ning Li; Yu-Qing Zheng; Xiao-Ping Yang; Ping Li; Hua Yang
Journal:  Chin Med       Date:  2022-04-01       Impact factor: 5.455

7.  Anti-inflammatory and antioxidant effects of MOK, a polyherbal extract, on lipopolysaccharide‑stimulated RAW 264.7 macrophages.

Authors:  Ji Hye Hwang; Jun Nan Ma; Jong Hun Park; Hyo Won Jung; Yong-Ki Park
Journal:  Int J Mol Med       Date:  2018-10-16       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.